On-Demand Session: Why "Ask Your Doctor" Isn’t Enough in a Virtual-First World
A framework for compliant, scalable DTC telehealth
Pharma has a problem: patients are moving faster than traditional access strategies. The old “ask your doctor” model can’t keep up. As digital-first care becomes the norm, virtual care is no longer optional—it’s a commercialization imperative.
In this on-demand session from Fierce Pharma Week 2025, Chris Moose, VP Life Sciences, shares a practical framework for embedding DTC telehealth into commercialization strategies. Through real-world scenarios, case studies, and actionable tools, you’ll see how leading brands are using virtual-first models to speed therapy starts, improve adherence, and expand patient reach—all while staying compliant.
"People are often making the same assumption about telehealth and virtual care, that it's an either or and it's not. We have the ability to link an in-person activity and virtual care and bring those together, whether it's labs or whether it's continuing on with a, a long-term chronic condition."
— Chris Moose, VP, Life Sciences, Wheel
Key Takeaways
- How to evaluate virtual care as a commercialization driver, not just a patient service
- How the 5-Point Virtual Care Fit Framework identifies high-opportunity therapies for smart investment
- What the media and Congress get wrong about DTC telehealth, and how to get it right
- How brands are embedding virtual access across the drug lifecycle, from pre-launch through LOE
- Real-world case studies showing DTC strategies in action
Featured Speaker
Experts from across the healthcare ecosystem, recorded live at Fierce Pharma Week 2025.
- Chris Moose, VP, Life Sciences, Wheel